Implementation of machine learning into clinical breast MRI: Potential for objective and accurate decision-making in suspicious breast masses
Stephan Ellmann(Universitätsklinikum Erlangen), Tobias Bäuerle(Johannes Gutenberg University Mainz), Sulaiman Vesal(Friedrich-Alexander-Universität Erlangen-Nürnberg), Peter A. Fasching(Universitätsklinikum Erlangen), Rüdiger Schulz Wendtland(Friedrich-Alexander-Universität Erlangen-Nürnberg), Evelyn Wenkel(BMW (Germany)), Matthias W. Beckmann(Universitätsklinikum Erlangen), Matthias Dietzel(Friedrich-Alexander-Universität Erlangen-Nürnberg), C Bielowski(Friedrich-Alexander-Universität Erlangen-Nürnberg), Michael Uder(SUNY Upstate Medical University), Matthias Hammon(Friedrich-Alexander-Universität Erlangen-Nürnberg), Andreas Maier(Friedrich-Alexander-Universität Erlangen-Nürnberg), Rolf Janka(Friedrich-Alexander-Universität Erlangen-Nürnberg)
Cited by 23
Related Papers
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
|The Lancet|2014|4.7k
Pembrolizumab for Early Triple-Negative Breast Cancer
|New England Journal of Medicine|2020|3.1k
Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes
|The American Journal of Human Genetics|2018|1.2k
Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk
|PLoS ONE|2015|906
Associations of Breast Cancer Risk Factors With Tumor Subtypes: A Pooled Analysis From the Breast Cancer Association Consortium Studies
|JNCI Journal of the National Cancer Institute|2010|716